Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice | Science Translational Medicine

Skip to main content

ScienceMag.org

Read our COVID-19 research and news.

Article Information

vol. 5 no. 206 206ra138

DOI:

https://doi.org/10.1126/scitranslmed.3006767

PubMed:

Published By:

American Association for the Advancement of Science

Print ISSN:

Online ISSN:

History:

Received for publication June 11, 2013
Accepted for publication September 17, 2013
.

Copyright & Usage:

Copyright © 2013, American Association for the Advancement of Science

Author Information

Julie A. Moreno¹,
Mark Halliday¹,
Colin Molloy¹,
Helois Radford¹,
Nicholas Verity¹,
Jeffrey M. Axten²,
Catharine A. Ortori³,
Anne E. Willis¹,
Peter M. Fischer⁴,
David A. Barrett³ and
Giovanna R. Mallucci¹,*

¹MRC Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE1 9HN, UK.
²GSK Oncology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA 19426, USA.
³Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
⁴Division of Medicinal Chemistry and Structural Biology, School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK.

↵*Corresponding author. E-mail: grm7{at}le.ac.uk

Altmetric

Article usage

Article usage: October 2013 to June 2021

	Abstract	Full	Pdf
Oct 2013	65449	3891	5460
Nov 2013	5741	485	517
Dec 2013	2978	169	242
Jan 2014	3087	160	237
Feb 2014	2233	101	139
Mar 2014	1713	128	155
Apr 2014	1406	78	105
May 2014	997	45	90
Jun 2014	851	42	74
Jul 2014	723	66	85
Aug 2014	494	41	61
Sep 2014	671	52	107
Oct 2014	867	106	171
Nov 2014	721	78	68
Dec 2014	557	71	72
Jan 2015	1262	194	146
Feb 2015	551	99	83
Mar 2015	879	94	85
Apr 2015	662	67	82
May 2015	631	86	67
Jun 2015	582	58	65
Jul 2015	667	63	68
Aug 2015	98	59	85
Sep 2015	75	51	68
Oct 2015	54	60	72
Nov 2015	43	54	76
Dec 2015	321	26	56
Jan 2016	1044	35	57
Feb 2016	973	87	72
Mar 2016	1051	88	58
Apr 2016	916	75	53
May 2016	974	58	43
Jun 2016	955	59	56
Jul 2016	889	27	34
Aug 2016	938	28	29
Sep 2016	863	57	55
Oct 2016	898	50	33
Nov 2016	863	49	34
Dec 2016	812	49	23
Jan 2017	844	32	21
Feb 2017	823	76	38
Mar 2017	920	24	37
Apr 2017	2383	154	169
May 2017	916	32	56
Jun 2017	786	39	28
Jul 2017	803	23	26
Aug 2017	728	25	39
Sep 2017	730	23	22
Oct 2017	801	28	24
Nov 2017	747	40	38
Dec 2017	796	22	24
Jan 2018	636	25	33
Feb 2018	575	41	35
Mar 2018	674	25	37
Apr 2018	924	54	40
May 2018	1010	23	30
Jun 2018	896	17	23
Jul 2018	590	18	22
Aug 2018	523	55	34
Sep 2018	649	43	24
Oct 2018	713	63	43
Nov 2018	642	52	29
Dec 2018	669	46	24
Jan 2019	648	31	16
Feb 2019	626	66	40
Mar 2019	569	68	25
Apr 2019	566	61	37
May 2019	284	48	35
Jun 2019	151	28	14
Jul 2019	196	28	24
Aug 2019	145	48	21
Sep 2019	175	33	13
Oct 2019	203	63	35
Nov 2019	163	62	24
Dec 2019	183	53	36
Jan 2020	209	64	27
Feb 2020	183	41	21
Mar 2020	183	40	14
Apr 2020	315	43	26
May 2020	265	49	23
Jun 2020	195	39	23
Jul 2020	178	41	20
Aug 2020	177	26	7
Sep 2020	222	50	38
Oct 2020	259	46	22
Nov 2020	223	49	15
Dec 2020	240	76	21
Jan 2021	318	70	31
Feb 2021	255	44	27
Mar 2021	274	38	16
Apr 2021	276	59	23
May 2021	325	49	23
Jun 2021	195	36	14

Science Translational Medicine: 5 (206)

Science Translational Medicine

Vol 5, Issue 206
09 October 2013

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Translational Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

Your Personal Message

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Powerpoint
Print
Alerts

Please log in to add an alert for this article.

Log In with your AAAS ID

Sign In to Email Alerts with your Email Address
Email
Citation tools
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

By Julie A. Moreno, Mark Halliday, Colin Molloy, Helois Radford, Nicholas Verity, Jeffrey M. Axten, Catharine A. Ortori, Anne E. Willis, Peter M. Fischer, David A. Barrett, Giovanna R. Mallucci

Science Translational Medicine09 Oct 2013 : 206ra138

Pharmacological inhibition of PERK, the key kinase of the unfolded protein response that mediates translational shutdown, restores protein synthesis in prion-infected mice, thus preventing neurodegeneration and clinical disease.

Supplementary Materials

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

By Julie A. Moreno, Mark Halliday, Colin Molloy, Helois Radford, Nicholas Verity, Jeffrey M. Axten, Catharine A. Ortori, Anne E. Willis, Peter M. Fischer, David A. Barrett, Giovanna R. Mallucci

Science Translational Medicine09 Oct 2013 : 206ra138

Pharmacological inhibition of PERK, the key kinase of the unfolded protein response that mediates translational shutdown, restores protein synthesis in prion-infected mice, thus preventing neurodegeneration and clinical disease.

Supplementary Materials
Share This Article:

My saved folders

Save to my folders

Log In with your AAAS ID

Stay Connected to Science Translational Medicine

Citing Articles in: